Lupin Limited — Others, 18-10-2024: Change in Management

Lupin Limited has announced the appointment of Mr. Claus Jepsen as President, Global Specialty, for its wholly owned subsidiary, Lupin Management, Inc., USA. Mr. Jepsen brings over 30 years of pharmaceutical experience, having previously held significant roles at Takeda Pharmaceuticals and GSK. His focus will be on advancing Lupin's specialty brand business and enhancing access to innovative medicines. This appointment is effective immediately and is not for a fixed term.